Pharmaron
30075937.722.71% ( -1.05 )
Pharmaron (300759)
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, th...
- Open
- 38.11
- High
- 38.77
- Low
- 37.46
- Prev. Close
- 38.77
- Volume
- 632.45K
- Turnover
- 2.40B
- Avg Price
- 37.88
- Bid/Ask Ratio
- --
- Amplitude
- 3.38%
- 52wk High
- 42.00
- Volume Ratio
- 0.51
- Turnover Ratio
- 4.28%
Pharmaron Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
¥37.730.03%
Forecast & RatingBuy
13analysts
- Strong buy53.85%
- Buy23.08%
- Hold15.38%
- Sell0.00%
- Strong sell7.69%
News
- AASTOCKS News · 1 day ago, 02:12 AM
Nomura Raises PHARMARON TP to HKD32.2 on Higher FY Revenue Forecast Driven by Order Backlog
- Tip Ranks · Jul 24 at 06:09 AM
Pharmaron Unveils 2026 H Share Incentive Plan and Governance Overhaul
- PUBT · Jul 22 at 03:40 AM
Pharmaron Beijing files HKEX next-day disclosure return reporting 5,396,470 new H shares issued
- AASTOCKS News · Jul 15 at 09:40 PM
HSBC Research Keeps PHARMARON at Buy, Expects Strong CDMO Growth to Offset FX Pressure
- Tip Ranks · Jul 15 at 07:26 PM
Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)
- AASTOCKS News · Jul 14 at 02:00 AM
UBS' Investment Ratings and TPs on CRO Stocks (Table)
